Register today to access recent news and articles.
Register

WhiteHawk

USA 14-01-2025

WhiteHawk Capital Partners provides $350M ABL facility to Nephron...

WhiteHawk Capital Partners has entered into an agreement with Nephron Pharmaceuticals to provide a US$350m asset-based credit facility. The financing will support a recapitalisation and provide liquidity for the company’s continued growth. Founded in 1997 by Lou and Bill Kennedy,...

#ABL#asset based lending#WhiteHawk

WhiteHawk Capital Partners provides $350M ABL facility to Nephron Pharmaceuticals
Our Sponsors
Our Events
View All

Webcastings

VIEW ALL
Jeff Longhurst, Non-Executive Director, Credebt 
UKIF25
Wayne Mills, Founder & Managing Director, Atom Advisory and...
UKIF25
Mansour Davarian, Managing Director, Co-Head Transaction Banking Solutions, Lloyds...
To top
BCR Publishing
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.